HK1204989A1 - 可吸入乾粉劑 - Google Patents
可吸入乾粉劑Info
- Publication number
- HK1204989A1 HK1204989A1 HK15105912.7A HK15105912A HK1204989A1 HK 1204989 A1 HK1204989 A1 HK 1204989A1 HK 15105912 A HK15105912 A HK 15105912A HK 1204989 A1 HK1204989 A1 HK 1204989A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dry powders
- inhalable dry
- inhalable
- powders
- dry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261605083P | 2012-02-29 | 2012-02-29 | |
US201261607928P | 2012-03-07 | 2012-03-07 | |
US201261645927P | 2012-05-11 | 2012-05-11 | |
US201261648506P | 2012-05-17 | 2012-05-17 | |
US201261707071P | 2012-09-28 | 2012-09-28 | |
PCT/US2013/028261 WO2013130767A1 (en) | 2012-02-29 | 2013-02-28 | Inhalable dry powders |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1204989A1 true HK1204989A1 (zh) | 2015-12-11 |
Family
ID=47884560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15105912.7A HK1204989A1 (zh) | 2012-02-29 | 2015-06-22 | 可吸入乾粉劑 |
Country Status (9)
Country | Link |
---|---|
US (4) | US20150136130A1 (zh) |
EP (1) | EP2819672A1 (zh) |
JP (3) | JP2015509788A (zh) |
CN (3) | CN104487075A (zh) |
AU (1) | AU2013225982B2 (zh) |
CA (1) | CA2865972C (zh) |
HK (1) | HK1204989A1 (zh) |
NZ (1) | NZ629722A (zh) |
WO (1) | WO2013130767A1 (zh) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
DE112008001301T5 (de) | 2007-05-14 | 2010-04-29 | Reserach Foundation Of State University Of New York | Induktion einer physiologischen Dispersions-Antwort in Bakterien-Zellen in einem Biofilm |
AU2011308865B2 (en) * | 2010-09-29 | 2017-01-05 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
SE1150190A1 (sv) * | 2011-03-02 | 2012-06-19 | Climatewell Ab Publ | Salt överdraget med nanopartiklar |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
GB201305825D0 (en) * | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
JP2016518388A (ja) | 2013-04-30 | 2016-06-23 | オティトピック インク. | 乾燥粉末配合および使用方法 |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
CA3111682A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
AU2015330923B2 (en) | 2014-10-07 | 2020-03-12 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
AU2015338717B2 (en) | 2014-10-31 | 2018-12-20 | Glaxosmithkline Intellectual Property Development Limited | Powder formulation |
SG11201707663SA (en) | 2015-04-17 | 2017-11-29 | Curevac Ag | Lyophilization of rna |
WO2016178704A1 (en) * | 2015-05-01 | 2016-11-10 | Board Of Regents, The University Of Texas System | Multidrug brittle matrix compositions |
EP3928800A3 (en) * | 2015-05-20 | 2022-03-23 | CureVac AG | Dry powder composition comprising long-chain rna |
US10517827B2 (en) * | 2015-05-20 | 2019-12-31 | Curevac Ag | Dry powder composition comprising long-chain RNA |
US10046007B2 (en) | 2015-06-24 | 2018-08-14 | Prescient Pharma, Llc | Compositions and methods for treatment of short telomere disorders |
MX2017016686A (es) * | 2015-07-13 | 2018-03-26 | Philip Morris Products Sa | Produccion de una composicion formadora de aerosol. |
WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
CN114904100A (zh) * | 2016-01-29 | 2022-08-16 | 曼金德公司 | 干粉吸入器 |
US10973786B2 (en) | 2016-03-11 | 2021-04-13 | Axcess Global Sciences, Llc | R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions |
US10596131B2 (en) | 2017-11-22 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
US10245242B1 (en) | 2017-11-22 | 2019-04-02 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
US10973792B2 (en) | 2019-02-13 | 2021-04-13 | Axcess Global Sciences, Llc | Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use |
US10245243B1 (en) | 2017-12-19 | 2019-04-02 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use |
US10596129B2 (en) | 2017-11-22 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
US10596130B2 (en) | 2017-12-19 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use |
US11185518B2 (en) | 2017-12-19 | 2021-11-30 | Axcess Global Sciences, Llc | S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer |
US11241403B2 (en) | 2016-03-11 | 2022-02-08 | Axcess Global Sciences, Llc | Beta-hydroxybutyrate mixed salt compositions and methods of use |
US11103470B2 (en) | 2017-11-22 | 2021-08-31 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
US10736861B2 (en) | 2016-03-11 | 2020-08-11 | Axcess Global Sciences, Llc | Mixed salt compositions for producing elevated and sustained ketosis |
IL310250A (en) | 2016-05-05 | 2024-03-01 | Liquidia Tech Inc | Terfostinil in dry powder form for the treatment of pulmonary hypertension |
UA126853C2 (uk) * | 2016-06-30 | 2023-02-15 | Філіп Морріс Продактс С.А. | Нікотиновмісні частинки |
JP6581308B2 (ja) * | 2016-10-17 | 2019-09-25 | 一般社団法人 金沢大整形 | 癌治療剤 |
DE102017006763A1 (de) * | 2017-07-18 | 2019-01-24 | Klaus Dieter Beller | Einzeldosis-Pulverinhalator |
US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
AU2017432640B2 (en) | 2017-09-22 | 2023-11-30 | Vectura Inc. | Dry powder compositions with magnesium stearate |
JP2020536123A (ja) * | 2017-10-02 | 2020-12-10 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | クロファジミンの吸入可能な組成物およびその使用方法 |
US11202769B2 (en) | 2017-11-22 | 2021-12-21 | Axcess Global Sciences, Llc | Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function |
US10925843B2 (en) | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
TWI827577B (zh) | 2018-01-12 | 2024-01-01 | 南韓商梅堤梅蒂製藥有限公司 | 治療慢性發炎疾病的方法 |
JP2021510723A (ja) * | 2018-01-26 | 2021-04-30 | ノバルティス アーゲー | 吸入型治療薬の高用量送達 |
US20200405983A1 (en) * | 2018-02-26 | 2020-12-31 | Shin Nippon Biomedical Laboratories, Ltd. | Powder preparation, cartridge, and device |
US11241401B2 (en) | 2020-02-06 | 2022-02-08 | Axcess Global Sciences, Llc | Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions |
US11806324B2 (en) | 2018-04-18 | 2023-11-07 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
JP2021522161A (ja) * | 2018-04-18 | 2021-08-30 | パルマトリックス オペレーティング カンパニー,インコーポレイテッド | イトラコナゾールを含む肺内投与のための抗真菌配合物 |
AU2019256453A1 (en) * | 2018-04-18 | 2020-11-12 | Cipla Technologies LLC | Methods of treating fungal infections |
US11419836B2 (en) | 2019-02-13 | 2022-08-23 | Axcess Global Sciences, Llc | Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions |
US11129802B2 (en) | 2018-08-27 | 2021-09-28 | Axcess Global Sciences, Llc | Compositions and methods for delivering cannabidiol and ketone bodies |
US10980772B2 (en) | 2018-08-27 | 2021-04-20 | Axcess Global Sciences, Llc | Compositions and methods for delivering tetrahydrocannabinol and ketone bodies |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
CN109089882B (zh) * | 2018-08-30 | 2022-02-08 | 云南省农业科学院花卉研究所 | 一种通过孢子直接诱导的苔藓组培及成苗培养方法 |
MX2021005999A (es) * | 2018-11-30 | 2021-07-06 | Balchem Corp | Composiciones de quelatos metalicos o complejos metalicos que comprenden nanoparticulas minimas. |
US11033553B2 (en) | 2019-06-21 | 2021-06-15 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
AU2020302077C1 (en) | 2019-06-26 | 2023-11-30 | The University Of Southern California | Compositions and methods for treatment of fungal infections |
WO2021071967A1 (en) * | 2019-10-09 | 2021-04-15 | Island Breeze Systems Ca, Llc | Compositions for pulmonary delivery of cannabinoids and associated methods and systems |
CN111358773B (zh) * | 2020-04-10 | 2021-03-30 | 广州南鑫药业有限公司 | 一种帕拉米韦干粉吸入剂及其制备方法 |
WO2021216710A1 (en) * | 2020-04-24 | 2021-10-28 | The Medical College Of Wisconsin, Inc. | Use of salmeterol as an anti-coronaviral agent |
WO2021262648A1 (en) * | 2020-06-23 | 2021-12-30 | Anovent Pharmaceutical (U.S.), Llc | Preparation of a pharmaceutical composition of olodaterol and budesonide |
IL299845A (en) | 2020-07-15 | 2023-03-01 | Schabar Res Associates Llc | Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn |
CN111690073B (zh) * | 2020-07-27 | 2021-11-26 | 西华师范大学 | 一种绒白乳菇多糖及其制备方法和应用 |
WO2022081814A1 (en) * | 2020-10-16 | 2022-04-21 | Michael Ogburn | Inhalable cannabinoid formulations |
DK4197528T3 (da) * | 2021-07-09 | 2024-05-06 | Astrazeneca Pharmaceuticals Lp | Sammensætninger, fremgangsmåder og systemer til indgivelse af medicin med aerosol |
CN114846943B (zh) * | 2022-06-10 | 2023-04-11 | 湖南亿恒环保工程有限公司 | 一种防止土壤酸化的土壤改良方法 |
US11969430B1 (en) | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
Family Cites Families (167)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
US4233405A (en) | 1979-10-10 | 1980-11-11 | Rohm And Haas Company | Process for spray drying enzymes |
DE3229179C2 (de) | 1982-08-05 | 1986-04-17 | A. Nattermann & Cie GmbH, 5000 Köln | Lungensurfactant |
US4637815A (en) | 1985-08-06 | 1987-01-20 | Lemole Gerald M | Irrigational hemostatic solution |
US4899914A (en) | 1988-11-04 | 1990-02-13 | Ciba-Geigy Corporation | Method for producing a sterile preservative-free aerosol saline solution |
IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
US5230884A (en) | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
US5175152A (en) | 1990-09-28 | 1992-12-29 | Singh Nikhilesh N | Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
US5571535A (en) | 1990-11-30 | 1996-11-05 | Flowers; Marianne | Treatment of topical infections |
JPH05123398A (ja) | 1991-11-06 | 1993-05-21 | Tsunemasa Kamiyama | 咽喉保護吸入剤並びに吸入器具 |
US5466680A (en) | 1992-03-26 | 1995-11-14 | Cytologics, Inc. | Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
JP3961029B2 (ja) | 1992-06-24 | 2007-08-15 | 博 木戸 | インフルエンザウィルス感染防止剤 |
US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US5898037A (en) | 1992-11-13 | 1999-04-27 | Marx; Alvin J. | Formulations of magnesium compounds for local application and methods of treatment using the same |
US5709202A (en) | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
NZ328476A (en) | 1993-06-24 | 1999-05-28 | Astra Ab | Use of a two component insulin preparation in an inhalation device |
FR2714782B1 (fr) | 1993-12-30 | 1996-02-02 | Alcatel Telspace | Estimateur en bande de base de la caractéristique amplitude/fréquence d'un signal à pluralités de phases. |
AUPM411494A0 (en) | 1994-02-25 | 1994-03-24 | Central Sydney Area Health Service | Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum |
US5468680A (en) | 1994-03-18 | 1995-11-21 | Massachusetts Institute Of Technology | Method of making a three-terminal fuse |
US5633003A (en) | 1994-03-31 | 1997-05-27 | Cantor; Jerome O. | Use of intratracheally administered hyaluronic acid to ameliorate emphysema |
JP3414539B2 (ja) | 1994-05-11 | 2003-06-09 | 有限会社ドット | 経鼻吸収用組成物 |
US6586006B2 (en) | 1994-08-04 | 2003-07-01 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
RU2161612C2 (ru) | 1994-10-14 | 2001-01-10 | Яманоути Фармасьютикал Ко., Лтд. | Производные азола, фармацевтическая композиция на их основе, промежуточные соединения |
US5863563A (en) | 1994-10-20 | 1999-01-26 | Alphagene Inc. | Treatment of pulmonary conditions associated with insufficient secretion of surfactant |
US5747002A (en) | 1995-04-05 | 1998-05-05 | Genentech, Inc. | Preparation of sodium chloride aerosol formulations |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US6165463A (en) | 1997-10-16 | 2000-12-26 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US5654007A (en) | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
US5628984A (en) | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
US6264854B1 (en) | 1995-09-07 | 2001-07-24 | Claude Q. C. Hayes | Heat absorbing temperature control devices and method |
US20050054682A1 (en) | 1996-01-04 | 2005-03-10 | Phillips Jeffrey O. | Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same |
GB9606677D0 (en) | 1996-03-29 | 1996-06-05 | Glaxo Wellcome Inc | Process and device |
US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
DE19653969A1 (de) | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
GB9707934D0 (en) | 1997-04-18 | 1997-06-04 | Danbiosyst Uk | Improved delivery of drugs to mucosal surfaces |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US5863084A (en) | 1997-12-04 | 1999-01-26 | Krug; Richard D. | Lifting aid device for a shovel |
TR200002855T2 (tr) | 1998-04-08 | 2000-12-21 | Eli Lilly And Company | Raloksifenin solunum yolu ile veya burundan uygulanması. |
US5883084A (en) | 1998-06-08 | 1999-03-16 | Clarion Pharmaceuticals Inc. | Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
FR2780285B1 (fr) | 1998-06-29 | 2001-10-05 | Goemar Lab Sa | Utilisation de solutions salines isoosmotiques, leur procede de preparation et medicaments anti-inflammatoires a base de ces solutions |
EP1100464A1 (en) | 1998-07-31 | 2001-05-23 | Korea Institute Of Science And Technology | Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
WO2000012063A1 (fr) | 1998-08-26 | 2000-03-09 | Teijin Limited | Compositions en poudre s'administrant par voie nasale |
US6333051B1 (en) | 1998-09-03 | 2001-12-25 | Supratek Pharma, Inc. | Nanogel networks and biological agent compositions thereof |
CA2343192C (en) | 1998-09-09 | 2005-03-15 | U.S. Army Institute Of Surgical Research | Pulse oximeter sensor combined with oropharyngeal airway and bite block |
US6926911B1 (en) | 1998-12-22 | 2005-08-09 | The University Of North Carolina At Chapel Hill | Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
US6355271B1 (en) | 1999-02-03 | 2002-03-12 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of manufacture and use |
AU4979700A (en) | 1999-05-03 | 2000-11-17 | Battelle Memorial Institute | Compositions for aerosolization and inhalation |
US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
JP2003507410A (ja) | 1999-08-25 | 2003-02-25 | アドバンスト インハレーション リサーチ,インコーポレイテッド | 乾燥粉末製剤からの放出調節 |
EP1210069B1 (en) | 1999-08-25 | 2004-12-29 | Advanced Inhalation Research, Inc. | Large porous particles obtainable by spray-drying and suitable for pulmonary administration |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
AU775565B2 (en) | 1999-10-29 | 2004-08-05 | Novartis Ag | Dry powder compositions having improved dispersivity |
NO314053B1 (no) | 1999-12-28 | 2003-01-20 | Norske Stats Oljeselskap | Momentkobling for bruk i borestreng |
WO2001049268A1 (en) | 2000-01-05 | 2001-07-12 | Imarx Therapeutics, Inc. | Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
AUPQ544900A0 (en) | 2000-02-04 | 2000-02-24 | Commonwealth Scientific And Industrial Research Organisation | Treatment of cellulosic material |
AU772096B2 (en) | 2000-03-14 | 2004-04-08 | Sumika Enviro-Science Co., Ltd. | Method for denaturing allergens |
SK284948B6 (sk) | 2000-04-06 | 2006-03-02 | Zentiva, A. S. | Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
MXPA02001323A (es) | 2000-05-10 | 2004-07-16 | Alliance Pharma | Microgranulos con base fosfolipida para la liberacion de farmaco. |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US6564108B1 (en) | 2000-06-07 | 2003-05-13 | The Delfin Project, Inc. | Method and system of auxiliary illumination for enhancing a scene during a multimedia presentation |
US7744855B2 (en) | 2000-06-27 | 2010-06-29 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
US7575761B2 (en) | 2000-06-30 | 2009-08-18 | Novartis Pharma Ag | Spray drying process control of drying kinetics |
US6669959B1 (en) | 2000-07-18 | 2003-12-30 | Aeropharm Technology Incorporated | Modulated release particles for lung delivery |
AU2001278131A1 (en) | 2000-08-01 | 2002-02-13 | Shofner Engineering Associates, Inc. | Generation, delivery, measurement and control of aerosol boli for diagnostics and treatments of the respiratory/pulmonary tract of a patient |
US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6572849B2 (en) | 2000-09-20 | 2003-06-03 | Lee Shahinian, Jr. | Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
ATE382335T1 (de) | 2000-11-30 | 2008-01-15 | Vectura Ltd | Verfahren zur vorbereitung von mikropartikeln zur verwendung in pharmazeutischen zusammensetzungen zur inhalation |
KR100743404B1 (ko) | 2000-12-21 | 2007-07-30 | 넥타르 테라퓨틱스 | 폴리엔 항균제의 폐 전달 |
CA2433280C (en) | 2000-12-27 | 2010-09-21 | Salus Pharma, Inc. | Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
US20020141946A1 (en) | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
EP1345629A2 (en) * | 2000-12-29 | 2003-09-24 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030138403A1 (en) | 2001-06-29 | 2003-07-24 | Maxygen Aps | Interferon formulations |
CN1254233C (zh) | 2001-08-06 | 2006-05-03 | 阿斯特拉曾尼卡有限公司 | 含有水不溶性的稳定纳米颗粒和赋形剂如中链甘油三酯(mct)的水性分散体 |
AU2002337692B2 (en) | 2001-09-26 | 2007-09-13 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
WO2003035028A1 (en) | 2001-10-19 | 2003-05-01 | Nektar Therapeutics | Modulating charge density to produce improvements in the characteristics of spray-dried proteins |
ATE396744T1 (de) | 2001-10-23 | 2008-06-15 | Innogel Ag | Netzwerk auf polysaccharidbasis und verfahren zu dessen herstellung |
PT1455755E (pt) | 2001-11-20 | 2013-06-18 | Civitas Therapeutics Inc | Composições particuladas melhoradas para distribuição pulmonar |
IL161446A0 (en) | 2001-11-26 | 2004-09-27 | Daiichi Suntory Pharma Co Ltd | Medicinal compositions for nasal absorption |
WO2003072080A1 (en) | 2002-02-22 | 2003-09-04 | Advanced Inhalation Research, Inc. | Inhalable formulations for sustained release |
US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
EP1531798B1 (en) | 2002-03-20 | 2012-06-06 | Civitas Therapeutics, Inc. | Pulmonary delivery for levodopa |
GB0207906D0 (en) | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and mometasone aerosol formulations |
AU2003243191B2 (en) | 2002-05-02 | 2007-09-20 | President And Fellows Of Harvard College | Formulations limiting spread of pulmonary infections |
US20050220720A1 (en) | 2002-05-02 | 2005-10-06 | David Edwards | Formulations limiting spread of pulmonary infections |
AU2003239433A1 (en) | 2002-05-13 | 2003-11-11 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
WO2003103832A2 (en) | 2002-06-05 | 2003-12-18 | University Technologies International Inc. | Oxygen reduction catalyst |
US7763278B2 (en) | 2002-06-10 | 2010-07-27 | Elan Pharma International Ltd. | Nanoparticulate polycosanol formulations and novel polycosanol combinations |
PT1531794T (pt) | 2002-06-28 | 2017-09-14 | Civitas Therapeutics Inc | Epinefrina inalável |
US20050288253A1 (en) | 2002-09-09 | 2005-12-29 | Trigen Limited | Boronic acid salts |
EP1556018A1 (en) | 2002-09-30 | 2005-07-27 | Acusphere, Inc. | Sustained release porous microparticles for inhalation |
KR20050085130A (ko) | 2002-11-22 | 2005-08-29 | 유 망 | 광범위 스펙트럼의 항-바이러스 치료제 및 예방제 |
WO2004062643A1 (en) | 2003-01-14 | 2004-07-29 | Lifecycle Pharma A/S | Dry dispersions |
US7534781B2 (en) | 2003-03-21 | 2009-05-19 | Dsm Ip Assets B.V. | Crystalline amoxicillin trihydrate powder |
CN1194062C (zh) | 2003-04-04 | 2005-03-23 | 王泽斌 | 一种融雪融冰组合物及其制备方法和应用 |
JP5037937B2 (ja) | 2003-05-01 | 2012-10-03 | イノジーン カルバイオテック プライベート リミティド | 乳酸塩含有医薬組成物及びその使用 |
EP1646370A1 (en) | 2003-07-11 | 2006-04-19 | Glaxo Group Limited | Pharmaceutical formulations |
GB0322358D0 (en) | 2003-09-24 | 2003-10-22 | Bioprogress Technology Ltd | Improvements in powder compaction and enrobing |
GB0324897D0 (en) | 2003-10-24 | 2003-11-26 | Glaxo Group Ltd | Composition |
GB0324918D0 (en) | 2003-10-24 | 2003-11-26 | Glaxo Group Ltd | Composition |
GB0326632D0 (en) * | 2003-11-14 | 2003-12-17 | Jagotec Ag | Dry powder formulations |
KR20050056622A (ko) | 2003-12-10 | 2005-06-16 | 주식회사 대우일렉트로닉스 | 플레쉬롬 다운로드 장치 |
EP1701714A2 (en) | 2004-01-07 | 2006-09-20 | Nektar Therapeutics | Improved sustained release compositions for pulmonary administration of insulin |
US20050207983A1 (en) | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
SE528121C2 (sv) | 2004-03-29 | 2006-09-05 | Mederio Ag | Preparering av torrpulver för på förhand uppmätt DPI |
WO2005094869A1 (en) | 2004-03-30 | 2005-10-13 | Malcolm King | Compositions and methods for improved mucus function |
JP2007530664A (ja) | 2004-03-30 | 2007-11-01 | ペインセプター ファーマ コーポレーション | ゲートイオンチャンネルを調節するための組成物及び方法 |
US20050281740A1 (en) | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue |
US7629385B2 (en) | 2004-06-29 | 2009-12-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Sphingolipid-derived pharmaceutical compositions |
DE102004031863B3 (de) | 2004-07-01 | 2006-03-09 | Airbus Deutschland Gmbh | Vorrichtung zur Fixierung von insbesondere flächenhaften Werkstücken mit einer Anlagefläche |
CN101090714A (zh) | 2004-07-26 | 2007-12-19 | 康泽里克斯公司 | 通过吸入伊洛前列素和微粒制剂治疗肺动脉高血压症 |
US20060073173A1 (en) | 2004-10-04 | 2006-04-06 | Maria Banach | Large-scale manufacturing process for the production of pharmaceutical compositions |
GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
US8627821B2 (en) | 2005-01-10 | 2014-01-14 | Pulmatrix, Inc. | Method and device for decreasing contamination |
WO2006102438A2 (en) | 2005-03-23 | 2006-09-28 | Ihc Intellectual Asset Management, Llc | Methods and compositions for irrigation of mucosal tissues |
DK1901749T3 (en) | 2005-05-18 | 2016-10-24 | Raptor Pharmaceuticals Inc | Aerosolized fluoroquinolones AND USES THEREOF |
US20070053844A1 (en) | 2005-05-18 | 2007-03-08 | Pulmatrix Inc. | Formulations for alteration of biophysical properties of mucosal lining |
US7838532B2 (en) * | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US7336883B2 (en) | 2005-09-08 | 2008-02-26 | Stratos International, Inc. | Indexing optical fiber adapter |
GB0520794D0 (en) | 2005-10-12 | 2005-11-23 | Innovata Biomed Ltd | Inhaler |
GB0523576D0 (en) | 2005-11-18 | 2005-12-28 | Theradeas Ltd | Drug composition and its use in therapy |
US20070202051A1 (en) | 2006-02-10 | 2007-08-30 | Pari Gmbh | Aerosols for sinunasal drug delivery |
KR100743181B1 (ko) | 2006-07-29 | 2007-07-27 | 주식회사 메가젠 | 치과용 응급 임플란트의 내부결합형 픽스츄어 |
EP1894865A1 (de) | 2006-08-31 | 2008-03-05 | Claudius Peters Technologies GmbH | Fördervorrichtung für pulverförmiges Gut |
WO2008025560A1 (en) | 2006-09-01 | 2008-03-06 | Pari Pharma Gmbh | Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy |
US20080063722A1 (en) | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
US20100099756A1 (en) | 2006-11-29 | 2010-04-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Uses of incensole, incensole acetate and derivatives thereof |
US8501255B2 (en) | 2006-12-14 | 2013-08-06 | Purac Biochem B.V. | Particulate composition comprising calcium lactate and calcium citrate microparticles |
GB0625322D0 (en) | 2006-12-19 | 2007-01-24 | Pharmakodex Ltd | Pharmaceutical compositions |
WO2008102438A1 (ja) | 2007-02-21 | 2008-08-28 | Fujitsu Microelectronics Limited | 半導体装置及びその製造方法 |
EP2011495A1 (en) | 2007-07-03 | 2009-01-07 | Sygnis Bioscience GmbH & Co. KG | Use of piperine and derivatives thereof for the therapy of neurological conditions |
WO2009037503A2 (en) | 2007-09-18 | 2009-03-26 | Astrazeneca Ab | New combination - 012 for the treatment of respiratory diseases |
EP2229364B1 (en) | 2007-12-05 | 2015-02-25 | Janssen Pharmaceutica, N.V. | Dibenzoazepine and dibenzooxazepine trpa1 agonists |
HUE031207T2 (hu) | 2008-01-11 | 2017-07-28 | Adheron Therapeutics Inc | Cadherin-11 EC1 domén elleni antitestek gyulladásos ízületi rendellenességek kezeléséhez |
EP2098219A1 (en) | 2008-03-05 | 2009-09-09 | PARI Pharma GmbH | Macrolide compositions having improved taste and stability |
AU2009246217B2 (en) | 2008-05-15 | 2013-01-10 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
EP2323640A2 (en) | 2008-08-04 | 2011-05-25 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Methods and compositions for treating neuronal damage and modulating transient receptor potential channels |
GB0818476D0 (en) | 2008-10-09 | 2008-11-12 | Vectura Delivery Device Ltd | Inhaler |
ES2426783T3 (es) | 2008-12-12 | 2013-10-25 | Georgios Pandalis | Extracto acuoso de Ribes para el tratamiento de infecciones virales |
US20110268775A1 (en) | 2009-01-06 | 2011-11-03 | Pharmanova, Inc. | Nanoparticle pharmaceutical formulations |
AU2010229724B2 (en) | 2009-03-26 | 2014-07-17 | Pulmatrix, Inc. | Pharmaceutical formulations and methods for treating respiratory tract infections |
AU2010229730A1 (en) | 2009-03-26 | 2011-10-06 | Pulmatrix, Inc. | Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
BRPI1011721B1 (pt) | 2009-03-26 | 2021-11-16 | Pulmatrix, Inc | Formulações em pó seco inaláveis compreendendo sal de cátion de metal divalente e métodos para tratar doenças pulmonares |
US20120058198A1 (en) | 2009-03-26 | 2012-03-08 | Pulmatrix, Inc. | Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis |
CA2754670A1 (en) | 2009-03-26 | 2010-09-30 | Pulmatrix, Inc. | Anti-influenza formulations and methods |
GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
US9433588B2 (en) | 2009-11-09 | 2016-09-06 | Virginia Commonwealth Univeristy | Delivery of submicrometer and nanometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery |
WO2012030664A1 (en) * | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
WO2012030645A1 (en) | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
US20120048900A1 (en) | 2010-08-30 | 2012-03-01 | Benjamin Ben-Kai Wong | Anatomically adaptive and ergonomic load distribution strap |
AU2011308865B2 (en) * | 2010-09-29 | 2017-01-05 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
PT106094A (pt) | 2012-01-13 | 2013-07-15 | Hovione Farmaciencia S A | Administração por inalação de formulações com dose elevada |
-
2013
- 2013-02-28 CN CN201380020063.7A patent/CN104487075A/zh active Pending
- 2013-02-28 CA CA2865972A patent/CA2865972C/en active Active
- 2013-02-28 WO PCT/US2013/028261 patent/WO2013130767A1/en active Application Filing
- 2013-02-28 NZ NZ629722A patent/NZ629722A/en unknown
- 2013-02-28 CN CN201910141714.7A patent/CN109999013A/zh active Pending
- 2013-02-28 AU AU2013225982A patent/AU2013225982B2/en active Active
- 2013-02-28 EP EP13709666.5A patent/EP2819672A1/en active Pending
- 2013-02-28 JP JP2014560032A patent/JP2015509788A/ja active Pending
- 2013-02-28 US US14/378,453 patent/US20150136130A1/en not_active Abandoned
- 2013-02-28 CN CN201710695234.6A patent/CN107596518B/zh active Active
-
2015
- 2015-06-22 HK HK15105912.7A patent/HK1204989A1/zh unknown
-
2017
- 2017-04-24 US US15/495,450 patent/US10589039B2/en active Active
- 2017-05-26 JP JP2017104816A patent/JP2017140515A/ja active Pending
-
2019
- 2019-07-10 JP JP2019128556A patent/JP2019181244A/ja active Pending
-
2020
- 2020-01-27 US US16/752,841 patent/US10806871B2/en active Active
- 2020-09-15 US US17/021,709 patent/US11235112B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2013130767A1 (en) | 2013-09-06 |
CA2865972C (en) | 2022-01-04 |
US20200261667A1 (en) | 2020-08-20 |
US20150136130A1 (en) | 2015-05-21 |
US20170304564A1 (en) | 2017-10-26 |
US10806871B2 (en) | 2020-10-20 |
AU2013225982B2 (en) | 2017-11-30 |
US20210060268A1 (en) | 2021-03-04 |
CA2865972A1 (en) | 2013-09-06 |
US11235112B2 (en) | 2022-02-01 |
EP2819672A1 (en) | 2015-01-07 |
JP2019181244A (ja) | 2019-10-24 |
CN109999013A (zh) | 2019-07-12 |
NZ629722A (en) | 2017-03-31 |
JP2017140515A (ja) | 2017-08-17 |
AU2013225982A1 (en) | 2014-09-18 |
CN107596518A (zh) | 2018-01-19 |
US10589039B2 (en) | 2020-03-17 |
JP2015509788A (ja) | 2015-04-02 |
CN104487075A (zh) | 2015-04-01 |
CN107596518B (zh) | 2021-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272629A (en) | Dry powder inhaler | |
HK1204989A1 (zh) | 可吸入乾粉劑 | |
HK1222127A1 (zh) | 乾粉吸入器 | |
HK1211187A1 (zh) | 吸入器 | |
EP2747815A4 (en) | dry powder inhaler | |
AU334237S (en) | Dry powder inhaler | |
HK1203424A1 (zh) | 吸入器 | |
AU345542S (en) | Inhaler | |
HK1221175A1 (zh) | 噻托溴銨乾粉 | |
GB201215282D0 (en) | An inhaler | |
PL2900303T3 (pl) | Inhalator | |
PL2729207T3 (pl) | Inhalator suchego proszku | |
HK1201130A1 (zh) | 電動粉撲 | |
GB201203383D0 (en) | Powder | |
GB201219759D0 (en) | Powder inhaler device | |
GB201207442D0 (en) | Powder ball | |
GB201215278D0 (en) | An inhaler |